UK Patent Registered to Physiomics

Physiomics plc has received formal notification from the UK Patent Office of registration to it in the UK of European Patent 0 937 286, which covers its SystemCell™ simulation technology. The corresponding US Patent 6,446,055 was granted on 3 September 2002 and assigned to Physiomics on 14 November 2002

Physiomics and Cronos Therapeutics to develop GeneICE for cancer treatment

Physiomics plc and Cronos Therapeutics Ltd (now ValiRx plc) have entered into an alliance whereby Physiomics will use its novel in silico technology to select optimal targets for the highly-selective GeneICE technology from Cronos Therapeutics. The alliance will then codevelop the lead GeneICE constructs.

Bayer Technology Services and Physiomics sign collaboration

Bayer Technology Services, the engineering and applied science spin-off company of Bayer AG, and Physiomics plc announced today an agreement to cooperate in the field of clinical response prediction.